Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
You can learn more about Dr
Skye is conducting a Phase 2a clinical trial (ClinicalTrials.gov: NCT06577090) in obesity for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1
Additionally, supply issues have affected availability in recent years, making consistent treatment challenging
Benefits of Gradual Weight Loss Helps preserve lean muscle mass Supports long-term weight maintenance Reduces the likelihood of rapid regain GLP-1 therapy for Weight Loss is designed to promote steady progress rather than rapid, short-term results
US$ 24.84
US$ 23.59
US$ 23.34
US$ 28.17
